Whitehawk Therapeutics, Inc. is an innovative oncology company based in Morristown, New Jersey, dedicated to developing targeted therapies that leverage proprietary technologies to deepen the understanding of tumor biology. The firm specializes in precision medicine, personalizing treatment regimens by considering the distinct biological features of individual tumors, which is expected to significantly enhance patient outcomes. With a strategic focus on advancing individualized oncology solutions, Whitehawk is well-positioned to make significant contributions to the field of cancer therapeutics and improve standards of patient care. Show more

Location: 2 HEADQUARTERS PLAZA, MORRISTOWN, NJ, UNITED STATES, 07960, Morristown, NJ, 07960, USA | Website: https://ir.whitehawktx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

127.2M

52 Wk Range

$1.39 - $3.77

Previous Close

$2.70

Open

$2.74

Volume

241,000

Day Range

$2.65 - $2.95

Enterprise Value

-35.35M

Cash

37.93M

Avg Qtr Burn

-15.38M

Insider Ownership

12.43%

Institutional Own.

67.19%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HWK-007 Details NSCLC, ovarian, endometrial cancers	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HWK-016 (MUC16 Targeted ADC) Details Ovarian And Endometrial Cancers	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.